| Title: | Regular use of paracetamol and risk of liver cancer: a prospective cohort study |
| Journal: | BMC Cancer |
| Published: | 4 Jan 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/38178090/ |
| DOI: | https://doi.org/10.1186/s12885-023-11767-5 |
| URL: | https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-023-11767-5 |
| Citations: | 1 (1 in last 2 years) as of 8 Aug 2024 |
Publication 8999
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundParacetamol induces hepatotoxicity and subsequent liver injury, which may increase the risk of liver cancer, but epidemiological evidence remains unclear. We conducted this study to evaluate the association between paracetamol use and the risk of liver cancer.MethodsThis prospective study included 464,244 participants free of cancer diagnosis from the UK Biobank. Incident liver cancer was identified through linkage to cancer and death registries and the National Health Service Central Register using the International Classification of Diseases (ICD)-10 codes (C22). An overlap-weighted Cox proportional hazards model was utilized to calculate the hazard ratio (HR) and 95% confidence interval (CI) for the risk of liver cancer associated with paracetamol use. The number needed to harm (NNH) was calculated at 10 years of follow-up.ResultsDuring a median of 12.6 years of follow-up, 627 cases of liver cancer were identified. Paracetamol users had a 28% higher risk of liver cancer than nonusers (HR 1.28, 95% CI 1.06-1.54). This association was robust in several sensitivity analyses and subgroup analyses, and the quantitative bias analysis indicated that the result remains sturdy to unmeasured confounding factors (E-value 1.88, lower 95% CI 1.31). The NNH was 1106.4 at the 10 years of follow-up.ConclusionThe regular use of paracetamol was associated with a higher risk of liver cancer. Physicians should be cautious when prescribing paracetamol, and it is recommended to assess the potential risk of liver cancer to personalize the use of paracetamol.</p>
19 Authors
- Liang Tian
- Ningning Mi
- Leiqing Wang
- Chongfei Huang
- Wenkang Fu
- Mingzhen Bai
- Long Gao
- Haidong Ma
- Chao Zhang
- Yawen Lu
- Jinyu Zhao
- Xianzhuo Zhang
- Ningzu Jiang
- Yanyan Lin
- Ping Yue
- Bin Xia
- Qiangsheng He
- Jinqiu Yuan
- Wenbo Meng
Enabling scientific discoveries that improve human health